SlideShare a Scribd company logo
1 of 20
Meta-regression with DisMod-MR:
how robust is the model?
June 18, 2013
Hannah M Peterson
Post-Bachelor Fellow
Global Burden of Disease Study 2010
2
YLDs
β€’ Measures morbidity
β€’ Requires age-specific prevalence
o For 291 outcomes
o For 2 sexes
o For 187 countries
o For 3 years
3
Is negative-binomial distribution
the best choice?
DisMod-MR
4
Alternative distributions
5
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
6
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
7
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
8
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Potential experimental frameworks
β€’ Data collection
o Ideal
o Impractical
β€’ Simulation
o Impossible to know true data distribution
β€’ Out-of-sample cross validation
o Do not have to choose distribution
9
Out-of-sample cross validation
10
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
11
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
12
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
13
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
β€’ Use fit to calculate statistics
for test data
14
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
β€’ Use fit to calculate statistics
for test data
β€’ For each distribution
β€’ For 1000 test-train splits
β€’ For each disease data set
15
Comparing distributions
16
How to determine the best distribution?
Metrics of evaluation
β€’
17
Results
18
Percent of wins (%)
Distribution Bias MAE PC Total
Normal 22.1 20.6 34.6 25.7
Lognormal 29.7 13.0 36.5 26.4
Binomial 26.3 48.3 1.9 25.5
Negative-
binomial
21.9 18.1 27.1 22.4
Conclusions
β€’ Choice of distribution doesn’t greatly influence results
β€’ Best overall performance: lognormal distribution
o Contingent on method to adjust data whose value is 0
β€’ Further investigate when each distribution performs best
o Dependent on number of covariates, priors, amount of data?
19
Thank you
Hannah Peterson
peterhm@uw.edu
www.healthmetricsandevaluation.org

More Related Content

What's hot

systematic review and metaanalysis
systematic review and metaanalysis systematic review and metaanalysis
systematic review and metaanalysis DrSridevi NH
Β 
6. Calculate samplesize for cohort studies
6. Calculate samplesize for cohort studies6. Calculate samplesize for cohort studies
6. Calculate samplesize for cohort studiesAzmi Mohd Tamil
Β 
Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨
Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨
Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨Parisa Mehran
Β 
Hypothesis testing
Hypothesis testingHypothesis testing
Hypothesis testingSumit Sharma
Β 
Null hypothesis for Mann Whitney U
Null hypothesis for Mann Whitney UNull hypothesis for Mann Whitney U
Null hypothesis for Mann Whitney UKen Plummer
Β 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confoundingIkram Ullah
Β 
Types of-qualitative-research
Types of-qualitative-researchTypes of-qualitative-research
Types of-qualitative-researchIntellspot
Β 
Inferential statistics powerpoint
Inferential statistics powerpointInferential statistics powerpoint
Inferential statistics powerpointkellula
Β 
Survival analysis
Survival analysisSurvival analysis
Survival analysisSanjaya Sahoo
Β 
L16 rm (systematic review and meta-analysis)-samer
L16 rm (systematic review and meta-analysis)-samerL16 rm (systematic review and meta-analysis)-samer
L16 rm (systematic review and meta-analysis)-samerDr Ghaiath Hussein
Β 
Sample size determination
Sample size determinationSample size determination
Sample size determinationGopal Kumar
Β 
Critical appraisal of published article
Critical appraisal of published articleCritical appraisal of published article
Critical appraisal of published articleYogesh Singhal
Β 
Randomized Controlled Trials
Randomized Controlled TrialsRandomized Controlled Trials
Randomized Controlled TrialsMamta Rath Datta
Β 
historical_background_research_ethics
historical_background_research_ethicshistorical_background_research_ethics
historical_background_research_ethicsDr Ghaiath Hussein
Β 
Application of statistical tests in Biomedical Research .pptx
Application of statistical tests in Biomedical Research .pptxApplication of statistical tests in Biomedical Research .pptx
Application of statistical tests in Biomedical Research .pptxHalim AS
Β 
Nudge - Book Summary
Nudge - Book SummaryNudge - Book Summary
Nudge - Book SummaryShiv Shivakumar
Β 

What's hot (20)

Types of bias
Types of biasTypes of bias
Types of bias
Β 
systematic review and metaanalysis
systematic review and metaanalysis systematic review and metaanalysis
systematic review and metaanalysis
Β 
6. Calculate samplesize for cohort studies
6. Calculate samplesize for cohort studies6. Calculate samplesize for cohort studies
6. Calculate samplesize for cohort studies
Β 
Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨
Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨
Being an Iranian Woman Today むラン人ε₯³ζ€§γ¨γ—γ¦ηΎδ»£γ«η”Ÿγγ‚‹γ¨γ„γ†γ“γ¨
Β 
Hypothesis testing
Hypothesis testingHypothesis testing
Hypothesis testing
Β 
Null hypothesis for Mann Whitney U
Null hypothesis for Mann Whitney UNull hypothesis for Mann Whitney U
Null hypothesis for Mann Whitney U
Β 
Sampling Methods
Sampling MethodsSampling Methods
Sampling Methods
Β 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
Β 
Types of-qualitative-research
Types of-qualitative-researchTypes of-qualitative-research
Types of-qualitative-research
Β 
Inferential statistics powerpoint
Inferential statistics powerpointInferential statistics powerpoint
Inferential statistics powerpoint
Β 
Survival analysis
Survival analysisSurvival analysis
Survival analysis
Β 
Systematic review
Systematic reviewSystematic review
Systematic review
Β 
L16 rm (systematic review and meta-analysis)-samer
L16 rm (systematic review and meta-analysis)-samerL16 rm (systematic review and meta-analysis)-samer
L16 rm (systematic review and meta-analysis)-samer
Β 
Sample size determination
Sample size determinationSample size determination
Sample size determination
Β 
Critical appraisal of published article
Critical appraisal of published articleCritical appraisal of published article
Critical appraisal of published article
Β 
Randomized Controlled Trials
Randomized Controlled TrialsRandomized Controlled Trials
Randomized Controlled Trials
Β 
historical_background_research_ethics
historical_background_research_ethicshistorical_background_research_ethics
historical_background_research_ethics
Β 
Application of statistical tests in Biomedical Research .pptx
Application of statistical tests in Biomedical Research .pptxApplication of statistical tests in Biomedical Research .pptx
Application of statistical tests in Biomedical Research .pptx
Β 
Nudge - Book Summary
Nudge - Book SummaryNudge - Book Summary
Nudge - Book Summary
Β 
Change Point | Statistics
Change Point | StatisticsChange Point | Statistics
Change Point | Statistics
Β 

More from Institute for Health Metrics and Evaluation - University of Washington

More from Institute for Health Metrics and Evaluation - University of Washington (20)

Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation PlanSalud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Β 
Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...
Β 
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Β 
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation PlanSalud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Β 
Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...
Β 
Salud MesoamΓ©rica Initiative: Select results from the baseline measurement
Salud MesoamΓ©rica Initiative: Select results from the baseline measurementSalud MesoamΓ©rica Initiative: Select results from the baseline measurement
Salud MesoamΓ©rica Initiative: Select results from the baseline measurement
Β 
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Β 
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Β 
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Β 
The Global Fund Prospective Country Evaluation
The Global Fund Prospective Country EvaluationThe Global Fund Prospective Country Evaluation
The Global Fund Prospective Country Evaluation
Β 
Prospective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis FindingsProspective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis Findings
Β 
Global Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findingsGlobal Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findings
Β 
Expected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking pointsExpected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking points
Β 
Global Health Financing
Global Health FinancingGlobal Health Financing
Global Health Financing
Β 
Maternal and Child Mortality in the United States
Maternal and Child Mortality in the United StatesMaternal and Child Mortality in the United States
Maternal and Child Mortality in the United States
Β 
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Β 
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi ArabiaChronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Β 
Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015
Β 
Understanding the costs of and constraints to health service delivery in Ghana
Understanding the costs of and constraints to health service delivery in GhanaUnderstanding the costs of and constraints to health service delivery in Ghana
Understanding the costs of and constraints to health service delivery in Ghana
Β 
ABCE: Understanding the costs of and constraints to health service delivery ...
ABCE: Understanding the costs of and constraints to health service delivery ...ABCE: Understanding the costs of and constraints to health service delivery ...
ABCE: Understanding the costs of and constraints to health service delivery ...
Β 

Recently uploaded

Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Scott Keck-Warren
Β 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Enterprise Knowledge
Β 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebUiPathCommunity
Β 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek SchlawackFwdays
Β 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
Β 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024The Digital Insurer
Β 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
Β 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
Β 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brandgvaughan
Β 
Training state-of-the-art general text embedding
Training state-of-the-art general text embeddingTraining state-of-the-art general text embedding
Training state-of-the-art general text embeddingZilliz
Β 
Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 3652toLead Limited
Β 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Manik S Magar
Β 
Commit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyCommit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyAlfredo GarcΓ­a Lavilla
Β 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024Stephanie Beckett
Β 
Powerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time ClashPowerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time Clashcharlottematthew16
Β 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxNavinnSomaal
Β 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
Β 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machinePadma Pradeep
Β 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
Β 

Recently uploaded (20)

Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024
Β 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
Β 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024
Β 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio Web
Β 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
Β 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Β 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024
Β 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Β 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
Β 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brand
Β 
Training state-of-the-art general text embedding
Training state-of-the-art general text embeddingTraining state-of-the-art general text embedding
Training state-of-the-art general text embedding
Β 
Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365
Β 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!
Β 
Commit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easyCommit 2024 - Secret Management made easy
Commit 2024 - Secret Management made easy
Β 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024
Β 
Powerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time ClashPowerpoint exploring the locations used in television show Time Clash
Powerpoint exploring the locations used in television show Time Clash
Β 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptx
Β 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
Β 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machine
Β 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Β 

Meta-regression with DisMod-MR: how robust is the model?

Editor's Notes

  1. Global Burden of Disease Study 2010 (GBD)-huge endeavor to measure health loss from disease, injuries, and risk using the Disability Adjusted Life Year (DALY)-coarsely described in the this 18-step process-I am just going to focus on a small subsection, the calculation of DALYs for injuries and disease-further narrow focus to the calculation of YLDsfigure:Murray, Ezzati, et. al. 2013. β€œGBD 2010: design, definitions, and metrics”. The Lancet. 380(9859):2063-2066.
  2. -YLDsmeasure morbidity, or years lived in less than full health-the YLD calculation needs age-specific prevalence estimates, for GBD, this means ---for 291 outcomes ---for 2 sexes---for 187 countries---for 3 years-however prevalence data is often less than ideal, -examples all available data in Western Europe for GDB2010 Study---sparse (fungal diseases) ---noisy (lower back pain) ---sparse and noisy (cannabis dependence data)-to calculate age-specific prevalence, used a tool called DisMod-MR
  3. -DisMod-MR is designed to address missing data and inconsistency ---used epidemiologic data and covariate data to calculate the age-specific prevalence based on a negative-binomial distribution---assumes all epidemiological data follows a negative-binomial distribution-is it really the best distribution to model the epidemiologic data?figure: Vos, Flaxman, et. al. 2013. β€œYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010”. The Lancet. 380(9859):2163-2196.
  4. Normalπœ‡=π‘šπ‘’π‘Žπ‘›πœŽ=π‘ π‘‘π‘Žπ‘›π‘‘π‘Žπ‘Ÿπ‘‘Β π‘‘π‘’π‘£π‘–π‘Žπ‘‘π‘–π‘œπ‘›-mathematically convenient-PROBLEM: allows negative estimates of prevalence, physiological impossibleNegative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  5. Lognormalπœ‡=π‘šπ‘’π‘Žπ‘›πœŽ=π‘ π‘‘π‘Žπ‘›π‘‘π‘Žπ‘Ÿπ‘‘Β π‘‘π‘’π‘£π‘–π‘Žπ‘‘π‘–π‘œπ‘›-bounds estimates at 0-PROBLEM: doesn’t allow prevalence to be 0---can’t take the log of 0-changed values of 0 to be 1 observation-other options would be to use an offset lognormal distribution-but somehow, have to work around estimates of 0Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  6. Binomial-which Dr. Flaxman already discussed-discrete model𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘ Β π‘‘π‘’π‘ π‘‘π‘’π‘‘π‘₯=π‘‘π‘’π‘ π‘‘π‘’π‘‘Β π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  7. Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘ Β π‘‘π‘’π‘ π‘‘π‘’π‘‘π‘₯=π‘‘π‘’π‘ π‘‘π‘’π‘‘Β π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to varyNegative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  8. Several ways to test which distribution is the best-ideal-data collection---actually go to country (region??) and measure age-specific prevalence---expensiveimpractical-simulation---great for testing, not for validation---problem: have to choose from what distribution the simulated data/measurements come------this is what we’re testing------simulation can showwhatever you want------impossible to know from what distribution measurement-out-of-sample cross validation---way to evaluate and compare distributions---shows how model performs in real life------can test out-of-sample predictive validity------don’t have to choose data distribution---concerns------unstable with sparse data-----------not just the epidemiologic data-----------also covariates and priors
  9. This experiment-57 different disease data sets---met inclusion criteria of more than 4 prevalence points in western europe---not a birth-condition meaning prevalence data is only at age 0-restricted to Western EuropeTo explain out-of-sample cross validation usedan example from GBD2010fungal diseases
  10. Randomly select 25% of data to withhold as test datatest data used to evaluate results
  11. Test data is withheld from DisMod-MR
  12. And the remaining data is fit
  13. From the fit, these estimates are compared to the test dataThis comparison of the estimate to the test data is where the statistics are calculatedthe same test-train split fits are created for each of the distribution so we can make a comparison
  14. -process repeated 1000 times with different test-train splits-repeated for 57 different disease data set---met inclusion criteria of more than 4 prevalence points in western europe---not a birth-condition meaning prevalence data is only at age 057 disease/injury conditions met this criteria
  15. metrics that capture different aspects of model performanceWant a model that is precise, accurate, well-calibrated -precise (bias)---measures average difference between the test data and prediction-accurate (median absolute error-MAE)---measure of overall error---many small errors create one large number---sensitive to mean and scale---less sensitive to outliers-calibrated (percent coverage-PC)---calibrated, meaning that our estimates are in the correct range of values------if we aim for 95% uncertainty, we expect 95% of our estimates to be good------more than that and the model is over confident------less than that and the model isn’t very good---percent of time the uncertainty interval of the prediction contains the observation---sensitive to discrete distributionsto determine which distribution performed the best, counted the the winner for each disease data set and split
  16. -for different metrics different distributions are superior---makes sense, since each distribution has it’s strengths and weaknesses---smallest bias: lognormal---minimum MAE: binomial---closest percent coverage: lognormal-concern about most frequent results and not raw numbers:---differences are small ------bias, ten-thousandths (E-4), average bias is negative binomial------mae, hundreds-overall winner: lognormal
  17. -previously saw, distribution choice doesn’t greatly influence DisMod-MR’s estimates of age-specific prev-results differ by metric-Best overall performance: lognormal distribution---STRESS:Contingent on method to adjust data whose value is 0-Further investigate when each distribution performs best---Dependent on number of covariates, priors, amount of data?DisMod-MR is robust in that choice of distribution for epidemiological values does not greatly influence estimates, but one distribution performs the best most frequently